Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Gritstone Oncology, Inc. | 985,360 | reported | 24 Jun 2024 | tx 14+3,394,623−674,263 |
| Adaptimmune Therapeutics PLC | 660,000 | reported | 01 Jul 2024 | tx 8+1,707,296 |
| Cullinan Therapeutics, Inc. | 79,456 | reported | 07 Aug 2025 | tx 1+79,456 |
| Epizyme, Inc. | 40,559 | reported | 11 Jun 2021 | tx 11+155,264−12,500 |
| Clovis Oncology, Inc. | 35,000 | reported | 02 Mar 2015 | tx 32+274,448−266,760 |
| PHARMION CORP | 0 | reported | 07 Mar 2008 | tx 29+77,700−67,800 |
| TCR2 THERAPEUTICS INC. | 0 | reported | 01 Jun 2023 | tx 11+47,270−65,342 |
| ProNAi Therapeutics Inc | 0 | reported | 01 Jul 2022 | tx 12+189,030−22,305 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Aug 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 79,456 | 0.00 USD | deriv |
| 01 Jul 2024 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 660,000 | 0.00 USD | deriv |
| 24 Jun 2024 | GIFT | Gritstone Oncology, Inc. | 325,000 | 0.00 USD | |
| 24 Jun 2024 | GIFT | Gritstone Oncology, Inc. | 325,000 | 0.00 USD | |
| 16 May 2024 | SALE | Gritstone Oncology, Inc. | 24,263 | 0.75 USD | |
| 15 May 2024 | GRANT_AWARD | Gritstone Oncology, Inc. | 47,873 | 0.00 USD | |
| 15 May 2024 | GRANT_AWARD | Gritstone Oncology, Inc. | 615,000 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | Gritstone Oncology, Inc. | 105,000 | 0.00 USD | |
| 01 Feb 2024 | GRANT_AWARD | Gritstone Oncology, Inc. | 615,000 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 56,868 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 152,376 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 109,746 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 109,746 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 45,348 | 0.00 USD | deriv |
| 05 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 73,212 | 0.00 USD | deriv |
| 03 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 500,000 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 8,072 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 6,270 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 12,100 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 5,000 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 12,100 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 16,800 | 0.00 USD | deriv |
| 02 Feb 2023 | GRANT_AWARD | Gritstone Oncology, Inc. | 738,550 | 0.00 USD | |
| 15 Dec 2022 | GRANT_AWARD | TCR2 THERAPEUTICS INC. | 16,800 | 0.00 USD | deriv |
| 01 Jul 2022 | OTHER | ProNAi Therapeutics Inc | 1,650 | 55.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 10 Dec 2018.